Patients Stopping Slimming Injections Put On Pounds Four Times Faster Compared to Dieters

New research reveals that patients who stop using blockbuster GLP-1 drugs like Wegovy and Mounjaro can put back on reduced body mass far faster than those who stop conventional lifestyle plans.

Published data in a major health publication demonstrates that while obese people frequently drop about a fifth of their total mass while using the jabs, the weight comes back at an average rate of 0.8 kg per month once they quit.

"Individuals buying these treatments need to be cognizant of the potential of fast rebound weight gain when the therapy is stopped," stated researcher Dr. Susan Jebb.

This pace of regain means a reversion to starting mass within about one and a half years.

Comparing Approaches

The analysis, which examined 37 of studies involving thousands of patients, compared the outcomes of these new drugs with other pills.

The team emphasize that people who lose weight through lifestyle changes alone usually see a slower creep back—around 0.1 kg a month—once they finish.

Understanding the Rapid Regain

Nutrition scientists propose the mode of action of the drugs explains the accelerated weight return.

These medications imitate a natural hormone called glucagon-like peptide-1, which controls feelings of fullness.

"Artificially providing the hormone levels several times higher than the body's typical production could lead to the body to produce less of its own natural GLP-1, and may also diminish sensitivity to its actions," explained Dr. Adam Collins, a nutrition expert.

"Withdrawal of this medication results in hunger is uncontrolled, making binge eating a significant risk."

A Chronic Issue?

Medical guidelines advise the jabs for people with weight-linked medical conditions, accompanied by recommended diet and exercise modifications.

Many experts argue that, considering the likelihood of weight regain, the therapy should be considered life-long.

This opinion is echoed by drug manufacturers, who say that the results "emphasize the chronic character of obesity," similar to managing diseases like hypertension.

User Experiences

Users who have stopped the medication report a intense return of appetite.

"It felt as if a trigger flipping and I was suddenly ravenous," said one woman.

The struggle is exacerbated if users have not established sustainable lifestyle or habit modifications during therapy.

Significant Use

Figures suggest that millions of adults in the UK have tried these injections in the past year, with interest remaining high.

• Adoption is higher among women than men.
• The 40s and 50s demographic shows the highest usage rates.
• Many access the drugs through private healthcare rather than the NHS.

Finally, clinicians emphasize that while the jabs are powerful agents for shedding pounds, they are not a magic cure and lasting health benefits likely depends on ongoing lifestyle changes.